drugset / Trial / NCT03107013
A Study to Investigate the Mass Balance of BTD-001
NaSingle-groupOpen-labelBasic science
Summary
This is a single-centre, open-label, non-randomised, single oral dose study in healthy male subjects to assess the mass balance recovery of carbon-14 (14C)-BTD-001.
Timeline
- Start
- 2017-04-03
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BTD-001 | Unknown | — | Oral |
Indications
No indication recorded.